A detailed history of Reyes Financial Architecture, Inc. transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Reyes Financial Architecture, Inc. holds 2,490 shares of AVXL stock, worth $21,214. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,490
Holding current value
$21,214
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$5.11 - $12.56 $12,723 - $31,274
2,490 New
2,490 $26.7 Million

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $664M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Reyes Financial Architecture, Inc. Portfolio

Follow Reyes Financial Architecture, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reyes Financial Architecture, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Reyes Financial Architecture, Inc. with notifications on news.